DIHYDROPYRIDAZINE-3,5-DIONE DERIVATIVE

According to the present invention, provided are a dihydropyridazine-3,5-dione derivative, a salt thereof, and solvates of the derivative and of the salt. Also provided are the following that contain any of said compounds as an active ingredient: a drug, a drug composition, a sodium-dependent phosph...

Full description

Saved in:
Bibliographic Details
Main Authors Kimbara, Atsushi, Tanaka, Shota, Tachibana, Kazutaka, Harada, Takeo, Ichida, Yasuhiro, Mizuguchi, Eisaku, Kashiwagi, Hirotaka, Okamoto, Naoki, Murata, Yoshihisa, Horiba, Naoshi, Ono, Yoshiyuki, Ohtomo, Shuichi, Nomura, Kenichi, Hori, Nobuyuki, Ide, Mitsuaki, Ohtake, Yoshihito
Format Patent
LanguageEnglish
Ukrainian
Published 11.03.2019
Subjects
Online AccessGet full text

Cover

Loading…
Abstract According to the present invention, provided are a dihydropyridazine-3,5-dione derivative, a salt thereof, and solvates of the derivative and of the salt. Also provided are the following that contain any of said compounds as an active ingredient: a drug, a drug composition, a sodium-dependent phosphate transporter inhibitor, and a prophylactic and/or therapeutic agent as well as a prophylactic and/or therapeutic method for hyperphosphatemia, secondary hyperparathyroidism, and chronic renal failure. Даний винахід пропонує похідне дигідропіридазин-3,5-діону або його сіль, або сольват сполуки або сольват солі сполуки, лікарський препарат, фармацевтичну композицію, інгібітор натрійзалежного транспортера фосфату і профілактичний і/або терапевтичний засіб при гіперфосфатемії, вторинному гіперпаратиреозі і хронічній нирковій недостатності, що включають сполуку як активний інгредієнт, і спосіб профілактики і/або лікування.
AbstractList According to the present invention, provided are a dihydropyridazine-3,5-dione derivative, a salt thereof, and solvates of the derivative and of the salt. Also provided are the following that contain any of said compounds as an active ingredient: a drug, a drug composition, a sodium-dependent phosphate transporter inhibitor, and a prophylactic and/or therapeutic agent as well as a prophylactic and/or therapeutic method for hyperphosphatemia, secondary hyperparathyroidism, and chronic renal failure. Даний винахід пропонує похідне дигідропіридазин-3,5-діону або його сіль, або сольват сполуки або сольват солі сполуки, лікарський препарат, фармацевтичну композицію, інгібітор натрійзалежного транспортера фосфату і профілактичний і/або терапевтичний засіб при гіперфосфатемії, вторинному гіперпаратиреозі і хронічній нирковій недостатності, що включають сполуку як активний інгредієнт, і спосіб профілактики і/або лікування.
Author Ohtake, Yoshihito
Okamoto, Naoki
Murata, Yoshihisa
Ohtomo, Shuichi
Kimbara, Atsushi
Ono, Yoshiyuki
Ide, Mitsuaki
Horiba, Naoshi
Kashiwagi, Hirotaka
Tachibana, Kazutaka
Harada, Takeo
Ichida, Yasuhiro
Hori, Nobuyuki
Nomura, Kenichi
Mizuguchi, Eisaku
Tanaka, Shota
Author_xml – fullname: Kimbara, Atsushi
– fullname: Tanaka, Shota
– fullname: Tachibana, Kazutaka
– fullname: Harada, Takeo
– fullname: Ichida, Yasuhiro
– fullname: Mizuguchi, Eisaku
– fullname: Kashiwagi, Hirotaka
– fullname: Okamoto, Naoki
– fullname: Murata, Yoshihisa
– fullname: Horiba, Naoshi
– fullname: Ono, Yoshiyuki
– fullname: Ohtomo, Shuichi
– fullname: Nomura, Kenichi
– fullname: Hori, Nobuyuki
– fullname: Ide, Mitsuaki
– fullname: Ohtake, Yoshihito
BookMark eNrjYmDJy89L5WRQc_H0iHQJ8g-IDPJ0cYzy9HPVNdYx1XXx9PdzVXBxDfIMcwzxDHPlYWBNS8wpTuWF0twM8m6uIc4euqkF-fGpxQWJyal5qSXxoY6GhhbmpqbORsaEVQAAIJokkQ
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate ПОХІДНЕ ДИГІДРОПІРИДАЗИН-3,5-ДІОНУ
ExternalDocumentID UA118755C2
GroupedDBID EVB
ID FETCH-epo_espacenet_UA118755C23
IEDL.DBID EVB
IngestDate Fri Jul 19 12:48:29 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
Ukrainian
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_UA118755C23
Notes Application Number: UAA201509770
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190311&DB=EPODOC&CC=UA&NR=118755C2
ParticipantIDs epo_espacenet_UA118755C2
PublicationCentury 2000
PublicationDate 20190311
PublicationDateYYYYMMDD 2019-03-11
PublicationDate_xml – month: 03
  year: 2019
  text: 20190311
  day: 11
PublicationDecade 2010
PublicationYear 2019
RelatedCompanies CHUGAI SEIYAKU KABUSHIKI KAISHA
RelatedCompanies_xml – name: CHUGAI SEIYAKU KABUSHIKI KAISHA
Score 3.1916869
Snippet According to the present invention, provided are a dihydropyridazine-3,5-dione derivative, a salt thereof, and solvates of the derivative and of the salt. Also...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title DIHYDROPYRIDAZINE-3,5-DIONE DERIVATIVE
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190311&DB=EPODOC&locale=&CC=UA&NR=118755C2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3NS8MwFH-MKepNp7L5uYP0ZNA2bdodinRJSiusK2Urm5fRdhuKoMN1-O_7Ujr1sltI4CV58HsfyfsAuEOAWY-ZaRCdLm1iMocRZ5nphPVQWzM0SHq5ShQeRCwYm88Ta9KA120uTFUn9LsqjoiIKhDvZSWvV3-PWKKKrVw_5G849fnkj1yh1d4xajeK2BV9V8ZDMeQa5-7Y06LEVV21LYujsN5DI9pWWJBpX-WkrP4rFP8Y9mOk9VGeQGPz3oJDvu271oKDQf3djcMaeetT0EQYTEUyjKdJKLyXMJKE3ltEoCiUXYHeWOqNwlSewa0vRzwguOHs926zsbc9GT2HJnr8izZ0C5vNHSNn1KCmKsjnGBk6MvO5oxcLQ6d5B9q7qFzsXrqEI8UhFUCl61fQLL82i2vUqGV-UzHjB41vdU0
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3NT8IwFH8haMSbogY_4WB2stGtWzcOixlrl01hLMsg4GXZYERjokRG_Pd9XUC9cGva5LV9ye99tO8D4BYBZjxkukZUujCJzixGrEWmEtZFbc3QIOnmMlF4EDJ_pD9NjEkNXre5MFWd0O-qOCIiaoZ4Lyt5vfx7xOJVbOXqPn_Dqc9HL7G5svGOUbtRxC7v2SIa8qGruK49cpQwtmVXbcNwUVjvoYFtSiyIcU_mpCz_KxTvCPYjpPVRHkNt_d6Ehrvtu9aEg8HmuxuHG-StTkDhgT_l8TCaxgF3XoJQEHpnEI6iUHQ4emNjJwnG4hTankhcn-CG6e_d0pGzPRk9gzp6_EULOjOTzS0tZ1SjuizIZ2kZOjLzuaXOCk2l-Tm0dlG52L3UhoafDPppPwifL-FQcksGU6nqFdTLr3Vxjdq1zG8qxvwAOFx4QA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=DIHYDROPYRIDAZINE-3%2C5-DIONE+DERIVATIVE&rft.inventor=Kimbara%2C+Atsushi&rft.inventor=Tanaka%2C+Shota&rft.inventor=Tachibana%2C+Kazutaka&rft.inventor=Harada%2C+Takeo&rft.inventor=Ichida%2C+Yasuhiro&rft.inventor=Mizuguchi%2C+Eisaku&rft.inventor=Kashiwagi%2C+Hirotaka&rft.inventor=Okamoto%2C+Naoki&rft.inventor=Murata%2C+Yoshihisa&rft.inventor=Horiba%2C+Naoshi&rft.inventor=Ono%2C+Yoshiyuki&rft.inventor=Ohtomo%2C+Shuichi&rft.inventor=Nomura%2C+Kenichi&rft.inventor=Hori%2C+Nobuyuki&rft.inventor=Ide%2C+Mitsuaki&rft.inventor=Ohtake%2C+Yoshihito&rft.date=2019-03-11&rft.externalDBID=C2&rft.externalDocID=UA118755C2